Home
Storia in 2 fonti
Big pharma firms have paused nearly £2bn in UK investments this year
Government’s plans in disarray before Trump talks as MSD, Eli Lilly and AstraZeneca moves prompt job fears
- ·
theguardian.com
Big pharma firms have paused nearly £2bn in UK investments this year
Government’s plans in disarray before Trump talks as MSD, Eli Lilly and AstraZeneca moves prompt job fears
- ·
cnbc.com
Pharma firms pile pressure on the UK as Trump's drug pricing order looms
A number of global pharma firms have pulled or paused U.K. investment plans amid waning government support and drug pricing talks.